NP Thyroid tablets from Acella Pharmaceuticals offer a reliable, trusted option for naturally desiccated thyroid containing levothyroxine (T4) and liothyronine (T3).
Phenazopyridne 100 mg and 200 mg tablets from Acella Pharmaceuticals is indicated to provide symptomatic relief of pain, burning, urgency, frequency and other discomforts of the urinary tract.
Acella Pharmaceutical’s FDA-Approved Tranexamic Acid Injection is approved for use in patients with hemophilia for short-term use to reduce or prevent hemorrhage.
Acella Pharmaceutical’s FDA-Approved Gabapentin Oral Solution is approved for the treatment of partial onset seizures in adult and pediatric patients and neuralgia in adults.
The mission of Acella Pharmaceuticals is to deliver quality products at affordable prices — bringing value to our customer base while providing savings and choice to patients nationwide.
Strategic partnerships are an integral component of Acella Pharmaceutical’s growth strategy. We value collaboration, and are focused on developing and building upon robust relationships and alliances.
Founded in 2007, Acella Pharmaceuticals, LLC is a specialty pharmaceutical company committed to “accelerating the health care solution” by bringing quality, affordable products to customers and patients.
Since its inception, Acella Pharmaceuticals has added more than 40 prescription products into its product portfolio, covering a diverse set of therapeutic areas.
Acella’s leadership team has more than 90 years of combined experience within the pharmaceutical industry, working in such specialties as pediatrics, nephrology, and cardiology, in positions of sales, marketing, manufacturing, and pharmaceutical distribution management. Click here to learn more.
ATLANTA – (Aug. 10, 2017) – Acella Pharmaceuticals, LLC, a leading U.S. manufacturer of specialty pharmaceuticals across several ther..
ATLANTA (July 27, 2017) - Acella Pharmaceuticals, LLC, a leading U.S. developer of specialty pharmaceuticals across several therapeutic categorie..
ATLANTA (Oct. 28, 2016) - Acella Pharmaceuticals, LLC, a specialty pharmaceutical company, recently secured approval for a sugar-free bioequivale..